SCHEMBL5744243

SCHEMBL5744243

Cc1c(C(C)(C)O[SiH2]C(C)(C)C)ccnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Imidazole SCHEMBL6613177 0.87 ALDH1A1 (0.33)
SCHEMBL5743434 0.80 NOS2 (0.44)
SCHEMBL11954926 0.76 TP53 (0.32)
SCHEMBL5312279 0.73 RECQL (0.33)
SCHEMBL5030111 0.71 PIK3CD (0.34)
SCHEMBL5743754 0.69
SCHEMBL501357 0.68 UHRF1 (0.39)
SCHEMBL2529902 0.67 KIF11 (0.38)
SCHEMBL5465608 0.67 NOS3 (0.40)
SCHEMBL5311884 0.64 DGAT1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404672-B1 TYROSINE KINASE INHIBITORS MERCK & CO INC (US) 2006-01-18 EP disclosed
US-6875767-B2 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors MERCK & CO., INC. (US) 2005-04-05 US disclosed
EP-1404672-A1 TYROSINE KINASE INHIBITORS Merck & Co., Inc. (US) 2004-04-07 EP disclosed
US-20030100567-A1 Tyrosine kinase inhibitors MERCK & CO., INC. 2003-05-29 US disclosed
WO-2003000687-A1 TYROSINE KINASE INHIBITORS MERCK & CO., INC. (US) 2003-01-03 WO disclosed